The pharmaceutical industry faces a significant challenge: securing the optimal balance between accelerated drug development and environmentally responsible practices. While the need for swift innovation to address global health concerns is undeniable, it's crucial to reduce the industry's ecological impact. This delicate balance demands a multifac